International Journal of Clinical Research

Objective To study the clinical implementation of TORCH infection screening, and whether it has an impact on eugenics and childbirth, and what specific aspects of the impact. Methods 506 pregnant women enrolled in the Department of Obstetrics and Gynecology of our hospital from September 2021 to June 2023 were selected as the specific study objects. The clinical data of 129 pregnant women with adverse pregnancy results were compared with 377 pregnant women with normal pregnancy results. Results The overall positive rate of IgM antibody was 11.66% in 506 patients. The positive rate of TORCH-IgG antibody and TORCH-IgM antibody were 16.97% and 8.48% respectively in the normal pregnancy group. The positive rate of TORCH-IgG antibody and TORCH-IgM antibody were 82.17% and 20.93% respectively in the abnormal pregnancy outcome group. The positive rates of TORCH-IgM and TORCH-IgG in pregnant women with abnormal pregnancy results were higher than those with normal pregnancy results, and the difference was statistically significant (P < 0.05). Conclusion Pregnant women are more likely to be infected with TORCH virus, and TORCH is closely related to the outcome of pregnancy reaction and eugenics, so it is necessary to strengthen the guidance of TORCH infection screening in women of childbearing age.

TORCH; Infection screening; Eugenic and eugenic; Influence